Hamman RF, Bell RA, Dabelea D, D’Agostino RB, Dolan L, Imperatore G et al (2014) The
SEARCH for diabetes in youth study: rationale, findings, and future directions. Diabetes Care
37(12):3336–3344
Hong S, Morrow TJ, Paulson PE, Isom LL, Wiley JW (2004) Early painful diabetic neuropathy is
associated with differential changes in tetrodotoxin-sensitive and -resistant sodium channels in
dorsal root ganglion neurons in the rat. J Biol Chem 279:29341–29350
International Diabetes Foundation (2019) International Diabetes Federation—facts & figures
Jaiswal M, Divers J, Dabelea D, Isom S, Bell RA, Martin CL et al (2017) Prevalence of and risk
factors for diabetic peripheral neuropathy in youth with type 1 and type 2 diabetes: search for
diabetes in youth study. Diabetes Care 40(9):1226–1232
Javed S, Petropoulos IN, Alam U, Malik RA (2015) Treatment of painful diabetic neuropathy. Ther
Adv Chronic Dis 6(1):15–28
Joseph EK, Levine JD (2004) Caspase signalling in neuropathic and inflammatory pain in the rat.
Eur J Neurosci 20(11):2896–2902
Kishi M, Tanabe J, Schmelzer JD, Low PA (2002) Morphometry of dorsal root ganglion in chronic
experimental diabetic neuropathy. Diabetes 51(3):819–824
Kukkar A, Bali A, Singh N, Jaggi AS (2013) Implications and mechanism of action of gabapentin in
neuropathic pain. Arch Pharm Res 36(3):237–251
Kurreck J (2006) siRNA efficiency: structure or sequence—that is the question. J Biomed
Biotechnol 2006:83757
Liang S, Xu C, Li G, Gao Y (2010) P2X receptors and modulation of pain transmission: focus on
effects of drugs and compounds used in traditional Chinese medicine. Neurochem Int 57(7):
705–712
Lindsay TJ, Rodgers BC, Savath V, Hettinger K (2010) Treating diabetic peripheral neuropathic
pain. Am Fam Physician 82(2):151–158
Lipp P, Reither G (2011) Protein kinase C: the “masters” of calcium and lipid. Cold Spring Harb
Perspect Biol 3:a004556
Liu C, Tao J, Wu H, Yang Y, Chen Q, Deng Z et al (2017) Effects of LncRNA BC168687 siRNA
on diabetic neuropathic pain mediated by P2X7 receptor on SGCs in DRG of rats. Biomed Res
Int 2017:7831251
Luo ZD, Calcutt NA, Higuera ES, Valder CR, Song YH, Svensson CI et al (2002) Injury type-
specific calcium channel α2δ-1 subunit up-regulation in rat neuropathic pain models correlates
with antiallodynic effects of gabapentin. J Pharmacol Exp Ther 303(3):1199–1205
Mamet J, Baron A, Lazdunski M, Voilley N (2002) Proinflammatory mediators, stimulators of
sensory neuron excitability via the expression of acid-sensing ion channels. J Neurosci 22(24):
10662–10670
Martin CL, Albers JW, Pop-Busui R (2014) Neuropathy and related findings in the diabetes control
and complications trial/epidemiology of diabetes interventions and complications study. Diabe-
tes Care 37(1):31–38
Maser RE, Steenkiste AR, Dorman JS, Nielsen VK, Bass EB, Manjoo Q et al (1989) Epidemiologi-
cal correlates of diabetic neuropathy. Report from Pittsburgh epidemiology of diabetes
complications study. Diabetes 38(11):1456–1461
McCarthy BG, Hsieh ST, Stocks A, Hauer P, Macko C, Cornblath DR et al (1995) Cutaneous
innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 45(10):1848–1855
McClelland D, Evans RM, Barkworth L, Martin DJ, Scott RH (2004) A study comparing the
actions of gabapentin and pregabalin on the electrophysiological properties of cultured DRG
neurones from neonatal rats. BMC Pharmacol 4:14
Meng QS, Yin Q, Li YP (2013) Nanocarriers for siRNA delivery to overcome cancer multidrug
resistance. Chin Sci Bull 58:4021–4030
Misawa S, Sakurai K, Shibuya K, Isose S, Kanai K, Ogino J et al (2009) Neuropathic pain is
associated with increased nodal persistent Na+ currents in human diabetic neuropathy. J
Peripher Nerv Syst 14(4):279–284
20
siRNA-Encapsulated Nanoparticles for Targeting Dorsal Root Ganglion (DRG). . .
383